Search results
Vertex (VRTX) Outperforms Industry on Rapid Pipeline Progress
Zacks via Yahoo Finance· 7 hours agoVertex Pharmaceuticals Incorporated Price and Consensus Vertex Pharmaceuticals Incorporated...
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded by StockNews.com to “Strong-Buy”
ETF DAILY NEWS· 2 days agoJPMorgan Chase & Co. boosted their target price on Vertex Pharmaceuticals from $390.00 to $438.00 and gave the stock an overweight rating ...
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 9 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know - Vertex Pharmaceuticals...
Benzinga· 6 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals . Looking at options history ...
Evercore ISI’s latest rating for VRTX stock – Knox Daily
Knox Daily· 2 days ago[NASDAQ:VRTX] saw its stock jump 1.04% to $445.21. Over the last five days, the stock has gained 5.31%. Vertex Pharmaceuticals ...
Is CRISPR Therapeutics Stock a Buy?
Motley Fool via Yahoo Finance· 4 days agoThese procedures must be performed in authorized treatment centers. CRISPR Therapeutics originally created Casgevy, but co-markets it with the much...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 6 days agoIs CRISPR stock a buy? CRISPR remains on track to start clinical trials for CTX112, a gene-editing...
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
Investor's Business Daily· 5 days agoThe biotech company showed 68% earnings growth last quarter. Sales gains came in at 21%. Halozyme...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoUnited Therapeutics stock also lands on the Tech Leaders list. Krystal Could Rival Vertex...
Is Bluebird Bio Stock a Buy?
Motley Fool via Yahoo Finance· 5 days agoCasgevy, another gene-editing treatment for SCD and TDT, earned approval recently. The team of Vertex Pharmaceuticals and CRISPR Therapeutics developed...
